Low Molecular Weight Heparin has 5 known drug interactions based on U.S. FDA drug labeling data. 4 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Carospir, Olsalazine Sodium, Spironolactone. Patients taking Low Molecular Weight Heparin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 5
- Major
- 4
- Moderate
- 1
Major (4)
- Low Molecular Weight Heparin + Carospir— Low molecular weight heparin may increase serum potassium, leading to severe hyperkalemia when used with CAROSPIR.
- Low Molecular Weight Heparin + Olsalazine Sodium— Co-administration may increase risk of bleeding and hematomas following neuraxial anesthesia. Discontinue olsalazine pri…
- Low Molecular Weight Heparin + Spironolactone— Low molecular weight heparin can increase serum potassium; concomitant use with spironolactone may lead to severe hyperk…
- Low Molecular Weight Heparin + Spironolactone And Hydrochlorothiazide— Concomitant administration may lead to severe hyperkalemia.
Moderate (1)
- Low Molecular Weight Heparin + Palifermin— Palifermin interacts with low molecular weight heparins; heparin increases systemic exposure of palifermin. Rinse IV lin…